Medifast Q3 revenue down 36% to $89.4M; net loss $2.3M; coaches drop 35%

MEDIFAST INC

2025-Q3 EPS reported -$0.05 revenue$310,692,000

Revenue $89.4M vs $140.2M YoY; net loss $0.21 per diluted share vs $0.10 income.
Active earning OPTAVIA coaches fell to 19,500 from 30,000, due to GLP-1 competition.
Gross margin 69.5% vs 75.4% on fixed-cost de-leverage and $180 basis pts for product reformulation.
Q4 2025 guidance: revenue $65M–$80M; diluted loss per share $0.70–$1.25.
Cash & investments $173.5M; no debt.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-25-048251
form_type: 8-K
ticker: MED
cik: 0000910329
company_name: MEDIFAST INC
filed_at: 2025-11-03T23:59:59+00:00
discovered_at: 2026-05-14T18:02:42.569816+00:00
generated_at: 2026-05-17T01:02:12.601434+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-25-048251
json_url: https://secwatch.observer/filing/0001628280-25-048251.json
markdown_url: https://secwatch.observer/filing/0001628280-25-048251.md
text_url: https://secwatch.observer/filing/0001628280-25-048251.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/0001628280-25-048251-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/med-20251103.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-25-048251

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.